Back to Sites

Saint Louis University Center for Vaccine Development

Site Number

30344

Address

1100 South Grand Blvd
First Floor
Saint Louis, MO 63104
United States of America

IMPAACT Members at this Site

Janice Tennant CRS Coordinator

Sharon Frey CRS Leader

Heidi Sallee MD CRS Leader

Studies at this Site

IMPAACT 2021: Randomized Phase I/II Study of the Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV delta NS2/ delta 1313/I1314L, RSV 6120/ delta NS2/1030s, RSV 276 or Placebo, Delivered as Nose Drops to RSV-Seronegative Children 6 to 24 Months of Age

DAIDS Number

Research Area

Complications & Comorbidities

Study Status